Le Haillan, Bordeaux, France
Le Haillan site was acquired from Créapharm group in 2005, when it was their R&D center. This allowed us to serve pharmaceutical companies wishing to outsource product development, and provided a platform for internal development of newly patented or non-patented formulations and technologies for our customers to license and market.
The site offers expertise in the development of all conventional dosage forms of New Chemical Entities at very early stages (Phase I and Phase II), and can rapidly manufacture clinical batches for initial trials.
The teams develop several generic products each year and tech-transfer to Unither’s industrial sites or to a site selected by the customer.
- Clinical batches in GMP facilities
- Turnkey products ready for market